Jeena Sikho Lifecare Ltd (NSE: JSLL) Q2 2025 Earnings Call dated Nov. 13, 2024
Corporate Participants:
Manish Grover — Managing Director
Nanak Chand — Chief Financial Officer
Analysts:
Ranvir Singh — Analyst
Sagar Jain — Individual Investor
Sumit Gupta — |Analyst
Chirag Shah — Analyst
Yash Gandhi — Analyst
Prerana Amanna — Analyst
K Rajesh — Individual Investor
Nishant Gupta — Analyst
Anurag Agrawal — Analyst
Akshay Kaila — Analyst
Isha Agarwal — Analyst
Priyam Khimawat — Analyst
Amit Jeswani — Analyst
Nitin Gupta — Individual Investor
Presentation:
Operator
Ladies and gentlemen, good day, and welcome to the Jeena Sikho Lifecare Limited H1 FY25 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. [Operator Instructions].
Please note that this conference is being recorded. I now hand the conference over to Mr. Ranvir Singh from Nuvama Wealth. Thank you, and over to you, sir.
Ranvir Singh — Analyst
Thank you, moderator. On behalf of Jeena Sikho Lifecare Limited, I extend a very warm welcome to all participants on H1 FY25 financial results discussion call. Today on our call, we have Mr. Manish Grover Ji, Managing Director; and Mr. Nanak Chand Ji, the CFO.
Before beginning with this call, I would like to give a short disclaimer. This call may contain some of the forward-looking statements which are completely based upon the management’s beliefs, opinions, and expectations as of today. These statements are not a guarantee of the company’s future performance and involve unforeseen risk and uncertainty.
With this, I would have to hand over the call to Mr. Manish Ji for his opening remarks. Over to you, sir. Manish, sir?
Manish Grover — Managing Director
[Foreign Speech].
Nanak Chand — Chief Financial Officer
Good afternoon, everyone. Thank you, Manish sir. As mentioned by Manish sir, we have achieved the healthy financial performance during the H1 FY25. Here are some key highlights. We generated revenue from operations and grew by 36% on year-on-year basis to INR214 crores, mainly driven by the hospital services, which has grew by 72%,Y-o-Y basis raised INR114 crores.
While product sales grew by 10% to INR100 crores, the EBITDA during the H1 FY25 grew by 32%, Y-o-Y basis to INR59.28 crores by implementing the EBITDA margin 28%. The H1 FY25 PAT grew by 47% Y-o-Y basis to INR46.88 crores. We retain a healthy balance sheet with net cash and equivalent of INR69 crores by end of the H1 FY25. Our ex-cash ROCE stood 82% respectively. And we also spent the INR16.72 crores in capex in H1 FY25.
Thank you so much.
Operator
Sir, should we open the floor for questions?
Nanak Chand — Chief Financial Officer
Sir, you can open floor for questions.
Questions and Answers:
Operator
Thank you very much. We will now begin the question-and-answer session. [Operator Instructions]. Our first question comes from Sagar Jain, Individual Investor. Please go ahead.
Sagar Jain
Hi, thanks for giving me the opportunity. Congratulations, Manish and Nanak for posting the very good results. However, I just have one question regarding the expansion that you are expanding to the 21 states of India and you have already crossed more than 100 towns of India.
So I just want to know that how this revenue is being generated majorly from the few hospitals or is evenly distributed, how it is coming from few locations of India or it is coming from every part of the 100 hospitals or maybe hospitals in 100 towns is coming from? So, how it is distributed?
Manish Grover
[Foreign Speech].
Sagar Jain
Yes, sir. Really thanks, sir. Even I am also a diabetic patient, so I definitely wish to —
Manish Grover
[Foreign Speech].
Sagar Jain
Absolutely, sir. Thanks, sir. I can see you and team are very aggressively trying to expand your business. Thank you. Thank you very much.
Operator
Thank you. The next question comes from Sumit Gupta from Centrum. Please go ahead.
Sumit Gupta
Hi, thank you for the opportunity, sir. I have two questions. First is on the hospital side. So, the kind of extension that you are going to do, just want to understand on the doctor cost point. So, how many doctors do you plan to — like, in overall doctor strength how much do you plan to increase and [Foreign Speech] overall?
Manish Grover
[Foreign Speech].
Sumit Gupta
Understood, sir. And sir, going forward, like I am seeing from FY23, your government revenue as percentage of overall revenue it has increased from 12% to 24%, which is double. So, going forward also, what kind of government empanelment do you see?
Manish Grover
[Foreign Speech].
Sumit Gupta
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Sumit Gupta
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Sumit Gupta
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Sumit Gupta
[Foreign Speech].
Manish Grover
[Foreign Speech].
Sumit Gupta
Okay sir, understood.
Manish Grover
[Foreign Speech].
Sumit Gupta
Okay sir, understood
Manish Grover
[Foreign Speech].
Sumit Gupta
Yes sir.
Operator
Thank you. The next question comes from Chirag from White Pine. Please go ahead. Chirag, your line is unmuted. Please proceed with your question.
Chirag Shah
Namaskar Acharya ji, [Foreign Speech].?
Manish Grover
Namaskar Chirag ji, [Foreign Speech].?
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
Okay.
Manish Grover
[Foreign Speech].
Chirag Shah
Okay. [Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
Okay, okay.
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech].
Manish Grover
[Foreign Speech].
Chirag Shah
[Foreign Speech]. Sir, all the best. I will come back for more questions.
Manish Grover
Thank you.
Operator
Thank you. The next question comes from Yash from Stallion Asset. Please go ahead.
Yash Gandhi
Hi, Manish Ji. Thank you again for the opportunity. Manish Ji, [Foreign Speech]?
Manish Grover
[Foreign Speech].
Yash Gandhi
Okay, okay. Thank you. [Foreign Speech]. Thank you.
Operator
Thank you. The next question comes from Prerana from Shome Partnership Limited. Please go ahead.
Prerana Amanna
Yeah. Hello, sir. Congratulations for a good set of numbers. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Prerana Amanna
[Foreign Speech]?
Manish Grover
[Foreign Speech].
.
Prerana Amanna
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Prerana Amanna
[Foreign Speech].
Manish Grover
[Foreign Speech].
Prerana Amanna
[Foreign Speech].
Manish Grover
[Foreign Speech].
Prerana Amanna
[Foreign Speech].
Manish Grover
[Foreign Speech].
Prerana Amanna
[Foreign Speech].
Manish Grover
[Foreign Speech].
Nanak Chand
Volume growth in medicine has increased by 10%. And in the service sectors, it has increased by 42% to 53%. In which way volume —
Prerana Amanna
Okay. Sir, this is the last question. [Foreign Speech].
Manish Grover
[Foreign Speech].
Prerana Amanna
Okay. [Foreign Speech].
Manish Grover
[Foreign Speech].
Prerana Amanna
All the best, sir. All the best.
Manish Grover
Okay. Thank you.
Operator
Thank you. The next question comes from K Rajesh, an Individual Investor. Please go ahead.
K Rajesh
Good afternoon, Manish sir. Hello?
Manish Grover
Ji, Namaskar.
K Rajesh
Namaskar Ji. Sir, congratulations for a very good set of numbers. And I think, we are going as per —
Operator
Mr. Rajesh, you are sounding a bit muffled. If you can use the handset, please?
K Rajesh
Yes. Hello?
Operator
Yes, sir.
Manish Grover
Ji, namaskar sir.
K Rajesh
Namaskar, sir. Sir, I think as per the numbers, we are going as per the guidance of INR450 crores. Can we expect INR1,000 crores revenue in FY26, sir? As per the bed occupancy, it is also increasing?
Manish Grover
[Foreign Speech].
K Rajesh
Sir, what about the main board plan? Are they going or not?
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech]?
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech]?
Manish Grover
Dubai, Vietnam, Mauritius, London, America, Australia, New Zealand, [Foreign Speech].
K Rajesh
[Foreign Speech]?
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech]?
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech].
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech]?
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech]?
Manish Grover
[Foreign Speech].
K Rajesh
[Foreign Speech]. Thank you, sir. Thank you for the results. Okay.
Operator
Thank you. The next question comes from Nishant Gupta from Minerva Global Capital. Please go ahead.
Nishant Gupta
Sir, thank you. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Nishant Gupta
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Nishant Gupta
Got it. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Nishant Gupta
Got it, sir. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Nishant Gupta
Okay. Thank you, sir.
Operator
Thank you. The next question is from Anurag Agrawal from Multify Wealth. Please go ahead.
Anurag Agrawal
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Anurag Agrawal
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Anurag Agrawal
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Anurag Agrawal
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Anurag Agrawal
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Anurag Agrawal
Right. Okay. Thank you for the information, Acharya Ji.
Manish Grover
Ji.
Operator
Thank you. The next question comes from Akshay from CD Integrated Services Limited. Please go ahead.
Akshay Kaila
Hello, sir. Am I audible?
Manish Grover
Ji Namaskar.
Akshay Kaila
Namaskar, sir. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Akshay Kaila
Okay, sir. [Foreign Speech]?
Manish Grover
Yes, sir. [Foreign Speech].
Akshay Kaila
Okay, right, sir. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Akshay Kaila
Okay, sir. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Akshay Kaila
Okay, sir. Okay. Thank you so much, sir. It was helpful.
Operator
Thank you. [Operator Instructions]. The next question comes from Isha from VT Capital. Please go ahead. Isha, your line is unmuted. Please proceed with your question.
Isha Agarwal
Yes, good afternoon, Acharya Ji.
Manish Grover
Ji, Namaskar.
Isha Agarwal
Congratulations on a very good set of numbers.
Manish Grover
[Foreign Speech].
Operator
Isha ma’am, can you please use the handset?
Isha Agarwal
Hello?
Manish Grover
[Foreign Speech].
Isha Agarwal
Congratulations on a good set of numbers. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Isha Agarwal
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Isha Agarwal
Okay. Thank you so much.
Manish Grover
Okay, ma’am. Thank you.
Operator
The next question comes from Priyam Khimawat from Ask Investment Managers. Please go ahead.
Priyam Khimawat
Namaskar, Acharya ji.
Manish Grover
Ji, Namaskar.
Priyam Khimawat
Acharya ji, [Foreign Speech]. So which is the best-selling therapy? Is it kidney? Is it liver? What is it?
Manish Grover
[Foreign Speech].
Priyam Khimawat
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Priyam Khimawat
Got it, got it. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Priyam Khimawat
On an average, if a doctor is having 10-year or five-year experience, what kind of annual income do they make?
Manish Grover
[Foreign Speech].
Priyam Khimawat
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Priyam Khimawat
Okay, sir. Got it, got it. All the best, Acharya Ji. You’re doing great job. Congratulations and continue doing the great job going ahead. Thank you.
Manish Grover
Thank you. [Foreign Speech].
Operator
Thank you. The next question comes from Amit Jeswani from Stallion Asset Private Limited. Please go ahead.
Amit Jeswani
[Foreign Speech]?
Manish Grover
[Foreign Speech]?
Amit Jeswani
All good. Thank you.
Manish Grover
[Foreign Speech].
Amit Jeswani
Thank you so much Manish Ji. [Foreign Speech]? I have no doubt on your capabilities but [Foreign Speech]? Still how are you managing your time?
Manish Grover
[Foreign Speech].
Amit Jeswani
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Amit Jeswani
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Amit Jeswani
In the Ayurveda medicine business?
Manish Grover
[Foreign Speech].
Amit Jeswani
[Foreign Speech].
Manish Grover
Thank you, sir.
Amit Jeswani
Thank you. Thank you so much.
Operator
Thank you. The next question comes from Akshay from CD Integrated Services Limited. Please go ahead.
Akshay Kaila
Hello, sir. [Foreign Speech]?
Manish Grover
[Foreign Speech].
Akshay Kaila
Okay, sir. Okay.
Manish Grover
[Foreign Speech].
Akshay Kaila
Right. Right, sir. Okay, sir. [Foreign Speech]. Thank you, sir. And all the best for the future, sir.
Operator
Thank you. The next question comes from Nitin Gupta, an Individual Investor. Please go ahead.
Nitin Gupta
Hello? Am I audible?
Manish Grover
Ji, Namaskar, sir.
Nitin Gupta
Namaskar, Manish Ji. [Foreign Speech]. To fund those expansions, do you have any plan to raise funds in the future? Or everything can be funded by internal approvals?
Manish Grover
[Foreign Speech].
Nitin Gupta
[Foreign Speech]?
Manish Grover
[Foreign Speech].
Nitin Gupta
[Foreign Speech]. Okay. That’s all from my side. Thank you.
Manish Grover
Thank you, sir.
Operator
Thank you. As there are no further questions from the participants, I now hand the conference over to the management for closing comments. Manish sir, you can give the closing remarks if there are any.
Manish Grover
[Foreign Speech]. Thank you very much. [Foreign Speech]. Thank you.
Operator
[Operator Closing Remarks].